Skip to main content

Table 2 HIV group: Clinical profile and aPL prevalence

From: Antiphospholipid antibodies in black south africans with hiv and acute coronary syndromes: prevalence and clinical correlates

  ACS+: HIV+ ACS-: HIV+ p value
Demographic Profile:    
Black African n(%) 30(100) 30(100) 1.0
Mean Age (years) 43 ± 7 41 ± 8 N/S
Men (%) 20(67) 19(63) N/S
HIV related factors:    
CD4(cells/mm3) median(range) 230 (30 -1356) 125 (6-1041) 0.013
Viral load (RNA copies/ml) median(range) 29000 (25 - 7 × 105) 54000(25-11 × 105) N/S
AIDS defining criteria n(%) 11(37) 21(70) 0.01
Current oppurtunistic infection 0 1(3) N/S
HIV related malignancies 0 2(7) N/S
Coronary risk factors n(%):    
Smoking 22(73) 11(37) 0.003
Diabetes Mellitus 1(3) 0(0) N/S
Hypertension 7(23) 2(7) N/S
Total cholesterol (mmol/l) 3.6 ± 1.0 3.7+/-0.8 N/S
LDL cholesterol (mmol/l) 2.2 ± 0.9 2.0 ± 0.5 N/S
HDL cholesterol (mmol/l) 0.8 ± 0.3 1.0 ± 0.5 0.011
Triglycerides (mmol/l) 1.4 ± 0.8 1.4+/-0.8 N/S
BMI (kg/m2) 25 ± 5 21 ± 4 0.003
Other coronary risk factors 2(7) 0(0) N/S
Baseline aPL frequencies (%):    
Blood samples n(%) 30(100) 30(100) 1.0
Anticardiolipin (IgG) 14/30(47) 17/30(57) N/S
Anticardiolipin (IgM) 3/30(10) 4/30(13) N/S
Anticardiolipin (IgA) 0/30(0) 0/30(0) N/S
Beta-2 Glycoprotein (IgG) 11/30(37) 10/30(33) N/S
Beta-2 Glycoprotein (IgM) 3/30(10) 2/30(7) N/S
Beta-2 Glycoprotein (IgA) 7/30(23) 8/30(27) N/S
Anti-Prothrombin (IgG) 26/30(87) 29/30(97) N/S
Anti-Prothrombin (IgM) 2/30(7) 0/30(0) N/S
Anti-Prothrombin (IgA) 2/30(7) 3/30(10) N/S
  1. Legend: Data are presented as the mean ± standard deviation or proportions
  2. Key: BMI = body mass index
  3. aPL = antiphospholipid antibody